Better sleep further supports metabolic health through improved insulin sensitivity and appetite hormone regulation
Using medication beyond this window increases contamination risk and may reduce treatment effectiveness
Metformin typically lowers A1C by 1-1.5% while Retatrutide shows reductions over 2%
The appropriate choice depends on the patients BMI, health history, previous treatment response, goals, and long-term preferences
It lowers blood sugar levels by increasing the release of insulin and decreasing the secretion of glucagon
GLP-1 coverage cuts: What shifting payer policies mean for prescribing, access, and utilization Feb 18th, 2026 Glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide (sold under brandnames Wegovy and Ozempic) and tirzepatide (Zepbound, Mounjaro) have transformed how physicians and patients approach treatment for type 2 diabetes and obesity